Χώρα: Ηνωμένες Πολιτείες
Γλώσσα: Αγγλικά
Πηγή: NLM (National Library of Medicine)
LANSOPRAZOLE (UNII: 0K5C5T2QPG) (LANSOPRAZOLE - UNII:0K5C5T2QPG)
American Sales Company
ORAL
OTC DRUG
Acid reducer
Abbreviated New Drug Application
CAREONE ACID REDUCER- LANSOPRAZOLE CAPSULE, DELAYED RELEASE AMERICAN SALES COMPANY ---------- AMERICAN SALES COMPANY ACID REDUCER DRUG FACTS ACTIVE INGREDIENT (IN EACH CAPSULE) Lansoprazole 15 mg PURPOS E Acid reducer US E • • WARNINGS ALLERGY ALERT: Do not use if you are allergic to lansoprazole DO NOT USE • ASK A DOCTOR BEFORE USE IF YOU HAVE • • • • • • • • • ASK A DOCTOR OR PHARMACIST BEFORE USE IF YOU ARE • STOP USE AND ASK A DOCTOR IF • • • treats frequent heartburn (occurs 2 OR MORE days a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor. liver disease had heartburn over 3 months. This may be a sign of a more serious condition. heartburn with LIGHTHEADEDNESS, SWEATING OR DIZZINESS chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness frequent CHEST PAIN frequent wheezing, particularly with heartburn unexplained weight loss nausea or vomiting stomach pain taking a prescription drug. Acid reducers may interact with certain prescription drugs. your heartburn continues or worsens you need to take this product for more than 14 days you need to take more than 1 course of treatment every 4 months • • IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). DIRECTIONS • • • 14-DAY COURSE OF TREATMENT • • • • • REPEATED 14-DAY COURSES (IF NEEDED) • • • OTHER INFORMATION • • • • • • INACTIVE INGREDIENTS D&C red no. 28, D&C yellow no. 10, FD&C blue no. 1, gelatin, hypromellose, low substituted hydroxypropyl cellulose, mannitol, meglumine, methacrylic acid copolymer, pharmaceutical ink, polyethylene glycol, polysorbate 80, sodium lauryl Διαβάστε το πλήρες έγγραφο